Across TCGA pan-cancer cohorts, MIR505 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated MIR505 data layer compared with 9 for mass-spec protein.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher MIR505 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated MIR505 expression acts as an unfavorable survival marker.

STAD are the cancer types where MIR505 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Median	II,III,IV	0.183	0.677	.004	24	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: MIR505 tumor-vs-normal RNA expression · all MIR505 data types